211 related articles for article (PubMed ID: 17635825)
1. New developments in the management of hyperphosphatemia in chronic kidney disease.
McIntyre CW
Semin Dial; 2007; 20(4):337-41. PubMed ID: 17635825
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
Malberti F
G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662
[TBL] [Abstract][Full Text] [Related]
4. Phosphorus balance with daily dialysis.
Kooienga L
Semin Dial; 2007; 20(4):342-5. PubMed ID: 17635826
[TBL] [Abstract][Full Text] [Related]
5. Phosphate is a uremic toxin.
Burke SK
J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
[TBL] [Abstract][Full Text] [Related]
6. Calcium-based phosphate binders are appropriate in chronic renal failure.
Friedman EA
Clin J Am Soc Nephrol; 2006 Jul; 1(4):704-9. PubMed ID: 17699276
[TBL] [Abstract][Full Text] [Related]
7. Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
Novak JE; Szczech LA
Semin Dial; 2009; 22(1):56-63. PubMed ID: 19000107
[TBL] [Abstract][Full Text] [Related]
8. The role of magnesium binders in chronic kidney disease.
Spiegel DM
Semin Dial; 2007; 20(4):333-6. PubMed ID: 17635824
[TBL] [Abstract][Full Text] [Related]
9. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
Malluche HH; Monier-Faugere MC
Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate.
Cozzolino M; Brancaccio D
Int J Artif Organs; 2007 Apr; 30(4):293-300. PubMed ID: 17520565
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
Cozzolino M; Pasho S; Missaglia E; Crovetto C; Fallabrino G; Brancaccio D
G Ital Nefrol; 2008; 25(2):234-7. PubMed ID: 18350504
[TBL] [Abstract][Full Text] [Related]
12. Salivary glands: a new player in phosphorus metabolism.
Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
[TBL] [Abstract][Full Text] [Related]
13. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
[TBL] [Abstract][Full Text] [Related]
14. Control of hyperphosphatemia among patients with ESRD.
Coladonato JA
J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of the non-calcium phosphate binder sevelamer.
Nikolov IG; Joki N; Maizel J; Lacour B; Drüeke TB; Massy ZA
Kidney Int Suppl; 2006 Dec; (105):S16-23. PubMed ID: 17136111
[TBL] [Abstract][Full Text] [Related]
16. Phosphate: a stealthier killer than previously thought?
Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake.
Uribarri J
Semin Dial; 2007; 20(4):295-301. PubMed ID: 17635818
[TBL] [Abstract][Full Text] [Related]
18. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction].
Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T
Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637
[TBL] [Abstract][Full Text] [Related]
19. [Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
Tanaka M
Clin Calcium; 2009 Feb; 19(2):194-7. PubMed ID: 19182358
[TBL] [Abstract][Full Text] [Related]
20. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
